Home › Funds › Krensavage Asset Management, LLC › BMRN
Krensavage Asset Management, LLC position in BMRN
BIOMARIN PHARMACEUTICAL INC COM · Health Care
Krensavage Asset Management, LLC reported holding 524,786 shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM) in its Q2 2026 13F filing — a position valued at US$30.0M, representing 11.41% of its reported portfolio and ranking #4 among its reported holdings. Krensavage Asset Management, LLC has disclosed BMRN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Krensavage Asset Management, LLC's BMRN position evolved
Krensavage Asset Management, LLC first disclosed a stake in BMRN in Q3 2025 at 405,450 shares (US$22.0M). The position peaked in Q4 2025 at 524,786 shares, worth US$31.2M. Across 4 filings, Krensavage Asset Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 524,786 shares valued at US$30.0M. Notable position changes include a 29% increase in Q4 2025 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 405.45K | $21.96M | New |
| Q4 2025 | 524.79K | $31.19M | Add |
| Q1 2026 | 524.79K | $29.64M | Hold |
| Q2 2026 | 524.79K | $30.03M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMRN and 13F data
BMRN (BIOMARIN PHARMACEUTICAL INC COM) is a Health Care company. 27 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMRN
- PRIMECAP MANAGEMENT CO/CA/ 14.19M sh · $811.96M · Q2 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.62M sh · $435.82M · Q2 2026
- Vestal Point Capital, LP 6.03M sh · $344.75M · Q2 2026
- Deep Track Capital, LP 3.31M sh · $189.25M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M sh · $108.89M · Q2 2026
More on Krensavage Asset Management, LLC
FAQ
How long has Krensavage Asset Management, LLC held BMRN?
Krensavage Asset Management, LLC has disclosed BMRN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Krensavage Asset Management, LLC's current position in BMRN?
As of Q2 2026, Krensavage Asset Management, LLC holds 524.79K shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM), valued at $30.03M, representing 11.41% of its reported portfolio and ranking #4.
Has Krensavage Asset Management, LLC been buying or selling BMRN?
In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC held unchanged its position in BMRN. The position peaked in Q4 2025 at 524.79K shares.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.